[email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
In a retrospective study published in BMJ Open Gastroenterology, investigators used the Merative MarketScan Research Databases to examine the outcomes of patients who received one of three treatment modalities: Semaglutide, bupropion-naltrexone or sleeve gastrectomy
In the context of semaglutide use, the medications effects on gastric emptying and gastrointestinal motility may exacerbate or contribute to heartburn symptoms
For example, semaglutide has been proven to decrease the risk of cardiovascular events such as stroke or heart attack [5]
la frecuencia y el tipo varan por producto
[DOI] [PubMed] [Google Scholar] Hllbrink M, Holmqvist T, Olsson M, stenson C-G, Efendic S, Langel